Elham Karamooz, MD | American Lung Association

Location Select your location

Elham Karamooz, MD

Research Awards Nationwide Recipient (2014-2016)

Oregon Health & Science University
Learning How Immune System Recognizes TB Bacteria Could Lead to New Vaccine

Mycobacterium tuberculosis (Mtb) is the second most common cause of infectious disease death worldwide and remains a significant global health threat. Unfortunately, the existing vaccine for TB, the BCG vaccine, does not confer enough protection in adults to curb the prevalence of Mtb. The difficulties in developing more effective vaccines stem from an incomplete understanding of how the immune system recognizes an Mtb-infected cell. We will focus on a type of immune cells called the Mucosal Associated Invariant T (MAIT) cells, which are capable of recognizing and killing Mtb infected cells. Our research will provide new information that could lead to new avenues for Mtb vaccine development.

Ask An Expert

Questions about your lung health? Need help finding healthcare? Call 1-800-LUNGUSA.

Get help
We need your generous support

Make a difference by delivering research, education and advocacy to those impacted by lung disease.

What is LUNG FORCE?

LUNG FORCE unites women and their loved ones across the country to stand together in the fight against lung cancer.

Get involved
Join the fight for healthy lungs and healthy air.
Donate Now.